EVAXION Trademark

Trademark Overview


On Thursday, February 10, 2022, a trademark application was filed for EVAXION with the United States Patent and Trademark Office. The USPTO has given the EVAXION trademark a serial number of 79342587. The federal status of this trademark filing is REGISTERED as of Tuesday, August 29, 2023. This trademark is owned by EVAXION BIOTECH A/S. The EVAXION trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Downloadable software for design of pharmaceuticals; downloadable artificial intelligence software for design of pharmaceuticals; downloadable artificial intelligence and machine learning software for design of pharmaceuticals; downloadable artificial intelligence software platforms for design of pharmaceuticals; downloadable software for evaluating medical treatment options and treatment outcomes for cancer; downloadable software for design and development of immunotherapy; downloadable software and downloadable artificial intelligence software for identifying antigens and epitopes; downloadable software and downloadable artificial intelligence software for designing and developing vaccines and medicines; downloadable software and downloadable artificial intelligence software for designing pharmaceuticals for cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis and parasites

Pharmaceuticals and medical preparations for treating cancer and infectious diseases; medicine for treatment of cancer; pharmaceuticals preparations and substances for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis, and parasites; biopharmaceuticals for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis, and parasites; immunotherapy preparations for treating cancer and infectious diseases; monoclonal antibodies (mAb) for medical purposes; vaccines for human use; viral vaccines; vaccine adjuvants; cells for medical use

Scientific and technological research services in the field of oncology, infectious diseases, and immunology; scientific research and development services in the fields of immunology and oncology; decoding of data; research and development of pharmaceuticals; medical and pharmacological research services; clinical medical research in the field of oncology, infectious diseases, and immunology; research and development of vaccines and medicines; scientific and technological research relating to virus, oncology, and autoimmune diseases; scientific and technological research relating to allergies
evaxion

General Information


Serial Number79342587
Word MarkEVAXION
Filing DateThursday, February 10, 2022
Status700 - REGISTERED
Status DateTuesday, August 29, 2023
Registration Number7147508
Registration DateTuesday, August 29, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 13, 2023

Trademark Statements


Goods and ServicesDownloadable software for design of pharmaceuticals; downloadable artificial intelligence software for design of pharmaceuticals; downloadable artificial intelligence and machine learning software for design of pharmaceuticals; downloadable artificial intelligence software platforms for design of pharmaceuticals; downloadable software for evaluating medical treatment options and treatment outcomes for cancer; downloadable software for design and development of immunotherapy; downloadable software and downloadable artificial intelligence software for identifying antigens and epitopes; downloadable software and downloadable artificial intelligence software for designing and developing vaccines and medicines; downloadable software and downloadable artificial intelligence software for designing pharmaceuticals for cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis and parasites
Goods and ServicesPharmaceuticals and medical preparations for treating cancer and infectious diseases; medicine for treatment of cancer; pharmaceuticals preparations and substances for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis, and parasites; biopharmaceuticals for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis, and parasites; immunotherapy preparations for treating cancer and infectious diseases; monoclonal antibodies (mAb) for medical purposes; vaccines for human use; viral vaccines; vaccine adjuvants; cells for medical use
Goods and ServicesScientific and technological research services in the field of oncology, infectious diseases, and immunology; scientific research and development services in the fields of immunology and oncology; decoding of data; research and development of pharmaceuticals; medical and pharmacological research services; clinical medical research in the field of oncology, infectious diseases, and immunology; research and development of vaccines and medicines; scientific and technological research relating to virus, oncology, and autoimmune diseases; scientific and technological research relating to allergies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 17, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEVAXION BIOTECH A/S
Party Type30 - Original Registrant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Party NameEVAXION BIOTECH A/S
Party Type20 - Owner at Publication
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Party NameEVAXION BIOTECH A/S
Party Type10 - Original Applicant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Trademark Events


Event DateEvent Description
Thursday, June 16, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, June 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 21, 2022APPLICATION FILING RECEIPT MAILED
Sunday, September 18, 2022NEW REPRESENTATIVE AT IB RECEIVED
Saturday, November 26, 2022ASSIGNED TO EXAMINER
Tuesday, November 29, 2022NON-FINAL ACTION WRITTEN
Wednesday, November 30, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 27, 2023REFUSAL PROCESSED BY MPU
Friday, January 27, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 21, 2023REFUSAL PROCESSED BY IB
Wednesday, May 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, May 10, 2023ASSIGNED TO EXAMINER
Wednesday, May 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 24, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 24, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 24, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, June 13, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2023NOTIFICATION PROCESSED BY IB
Tuesday, June 13, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 29, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 29, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, November 29, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, February 1, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 4, 2023FINAL DISPOSITION PROCESSED
Monday, December 4, 2023FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, December 26, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 24, 2025NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 1, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 1, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 1, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS